---
title: "HOTH.US (HOTH.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/HOTH.US/news.md"
symbol: "HOTH.US"
name: "HOTH.US"
parent: "https://longbridge.com/en/quote/HOTH.US.md"
datetime: "2026-05-20T22:24:10.340Z"
locales:
  - [en](https://longbridge.com/en/quote/HOTH.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HOTH.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HOTH.US/news.md)
---

# HOTH.US (HOTH.US) — Related News

### [EXCLUSIVE: Hoth Therapeutics To Rebrand To Pursue AI Chip Technologies](https://longbridge.com/en/news/286908929.md)
*2026-05-19T11:46:09.000Z*
> Hoth Therapeutics Inc. plans to rebrand as Rocket One Inc. to focus on AI semiconductor technologies and ultra-low-power

### [AI Chip Energy Efficiency: Hoth Therapeutics Restructures as Rocket One Inc. to Enter the AI Semiconductor Infrastructure Market with Acquisition of Exclusive Rights to Next Generation AI Semiconductor Acceleration Technology Built on Non-Volatile Nanomagnetic Semiconductor Architecture | HOTH Stock News](https://longbridge.com/en/news/286911204.md)
*2026-05-19T04:17:00.000Z*
> Hoth Therapeutics is restructuring and rebranding as Rocket One, Inc. to enter the AI semiconductor market. The company 

### [16:17 ETHoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients](https://longbridge.com/en/news/285259554.md)
*2026-05-05T20:17:21.000Z*
> Hoth Therapeutics, Inc. has received regulatory authorization in Spain for its Phase 2a CLEER Trial of HT-001, aimed at 

### [Weekly Buzz: FDA Okays TVTX, PHG; Rejects REPL; AIP Snaps Up AVNS; PDS, HOTH, SYRE, Paces Trials](https://longbridge.com/en/news/283163257.md)
*2026-04-17T14:40:42.000Z*
> This week's biotech news highlights significant regulatory approvals and rejections, including FDA clearance for Royal P

### [Hoth Therapeutics Resumes At-the-Market Equity Offering Program](https://longbridge.com/en/news/283065779.md)
*2026-04-16T22:01:15.000Z*
> Hoth Therapeutics, Inc. has resumed its At-the-Market Equity Offering Program after previously suspending it. The compan